Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$835,053
+$31,335 QoQ
Shares Held
3,288
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3,192
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. JNJ ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
282,442 | $71,073,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
421,984 | $53,313,458 | |
| 3 | NVS |
Novartis AG
|
317,429 | $49,747,472 | |
| 4 | AMGN |
Amgen Inc
|
108,134 | $39,157,483 | |
| 5 | SNY |
Sanofi
|
674,143 | $28,758,939 | |
| 6 | NVO |
Novo Nordisk A S
|
134,460 | $6,446,012 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
3,288 | $835,053 | |
| 8 | PFE |
Pfizer Inc
|
27,801 | $669,448 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $835,053 | 3,288 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $803,718 | 3,288 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $680,451 | 3,288 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $609,660 | 3,288 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $502,242 | 3,288 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $545,281 | 3,288 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $475,510 | 3,288 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $532,853 | 3,288 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $480,574 | 3,288 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $520,128 | 3,288 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $515,361 | 3,288 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $512,106 | 3,288 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $544,229 | 3,288 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $509,640 | 3,288 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $580,825 | 3,288 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $537,127 | 3,288 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $583,652 | 3,288 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $582,732 | 3,288 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $562,478 | 3,288 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $531,012 | 3,288 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $541,665 | 3,288 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $540,382 | 3,288 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $517,465 | 3,288 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $489,517 | 3,288 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $467,313 | 3,323 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $435,744 | 3,323 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||